DNA methyltransferase 1 expression and promoter methylation of E‐cadherin in mucoepidermoid carcinoma
Authors:
- Yi‐Shing ShiehYSYi‐Shing Shieh
- Shine‐Gwo ShiahSSShine‐Gwo Shiah
- Hao‐Hsuan JengHJHao‐Hsuan Jeng
- Herng‐Sheng LeeHLHerng‐Sheng Lee
- Cheng‐Wen WuCWCheng‐Wen Wu
- Long‐Chang ChangLCLong‐Chang Chang
Open Access
Abstract
BACKGROUND: Loss of E‐cadherin expression is found frequently in many types of human malignancies, including mucoepidermoid carcinoma (MEC). CpG methylation in the promoter region has proven important in the regulation of gene expression implicated in malignant transformation. DNA methyltransferases (DNMTs) are the major enzymes involved in establishing genomic methylation patterns. The current study was designed to test the hypothesis that CpG methylation of the promoter region of the E‐cadherin gene may inactivate its expression and to examine DNMT 1 (DNMT1) protein expression in MEC.METHODS: Genomic DNA was obtained from paraffin embedded sections by laser microdissection in 46 MEC specimens. Methylation status of the E‐cadherin promoter was examined by utilizing the methylation‐specific polymerase chain reaction assay. To examine E‐cadherin and DNMT1 proteins expression levels, the MEC specimens and adjacent epithelial tissues were studied immunohistochemically. Chi‐square analysis was used to evaluate the correlation of protein expression and E‐cadherin methylation status with clinicopathologic parameters. Comparisons of the survival rate between patients with DNMT1‐positive and DNMT1‐negative patients were made using Kaplan–Meier analysis.RESULTS: The data showed that all normal tissues expressed E‐cadherin, and no promoter methylation was detected. Of the MEC samples analyzed, methylation allele was found in 33 of 46 samples (72%), and reduced E‐cadherin expression was found in 21 of 46 samples (45%). DNMT1‐positive expression was observed in 29 of 46 MEC samples (63%). A significant correlation was found between E‐cadherin expression and the methylation status of E‐cadherin promoter (P = 0.021). In addition, increased DNMT1 expression was correlated with histologic grade, clinical stage, and a poor prognosis in patients with MEC.CONCLUSIONS: Hypermethylation of CpG sites at the 5′ promoter of E‐cadherin was a common event associated with E‐cadherin expression levels in MEC, suggesting an epigenetically mediated loss of E‐cadherin function in these tumors. Increased DNMT1 protein expression may play a critical role in the carcinogenesis and disease progression of MEC. Cancer 2005. © 2005 American Cancer Society.Keywords
This publication has 40 references indexed in Scilit:
- Increased DNA Methyltransferase 1 (DNMT1) Protein Expression Correlates Significantly with Poorer Tumor Differentiation and Frequent DNA Hypermethylation of Multiple CpG Islands in Gastric CancersThe American Journal of Pathology, 2004
- DNA methylation and chromatin – unraveling the tangled webOncogene, 2002
- The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14ARF, p16INK4a and RASSF1A in human lung cancer cell linesOncogene, 2002
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002
- Methylation of the E-cadherin Gene in Bladder Neoplasia and in Normal Urothelial Epithelium from Elderly IndividualsThe American Journal of Pathology, 2001
- Histone Deacetylase and DNA Methyltransferase in Human Prostate CancerBiochemical and Biophysical Research Communications, 2001
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature Cell Biology, 2000
- Suppression of intestinal neoplasia by DNA hypomethylationCell, 1995
- Cadherin Cell Adhesion Receptors as a Morphogenetic RegulatorScience, 1991
- Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cellsJournal of Molecular Biology, 1988